Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-12-12

Clinical Trial Update: Efficacy and Tolerability of Angeliq in Thai Women [Phase 4]

View source ↗

Summary

A Phase 4 trial assessed the efficacy and tolerability of Angeliq in Thai women undergoing menopause; the study has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ANGELIQ (DROSPIRENONE AND ESTRADIOL)

Snippet

Sponsor: Bayer | Conditions: Postmenopause | Phase 4 | Status: COMPLETED